Xiaoshan Zhao

1.9k total citations
86 papers, 1.2k citations indexed

About

Xiaoshan Zhao is a scholar working on Molecular Biology, Nephrology and Pharmacology. According to data from OpenAlex, Xiaoshan Zhao has authored 86 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Nephrology and 14 papers in Pharmacology. Recurrent topics in Xiaoshan Zhao's work include Pharmacological Effects of Natural Compounds (11 papers), Gout, Hyperuricemia, Uric Acid (10 papers) and Traditional Chinese Medicine Studies (8 papers). Xiaoshan Zhao is often cited by papers focused on Pharmacological Effects of Natural Compounds (11 papers), Gout, Hyperuricemia, Uric Acid (10 papers) and Traditional Chinese Medicine Studies (8 papers). Xiaoshan Zhao collaborates with scholars based in China, Hong Kong and Australia. Xiaoshan Zhao's co-authors include Ren Luo, Yanting You, Shuang Li, Hiu Yee Kwan, Yanyan Liu, Ya Xiao, Liqian Chen, Xinghong Zhou, Xiaomin Sun and Xiu‐Qiong Fu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Xiaoshan Zhao

79 papers receiving 1.1k citations

Peers

Countries citing papers authored by Xiaoshan Zhao

Since Specialization

Citations

This map shows the geographic impact of Xiaoshan Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoshan Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoshan Zhao more than expected).

Fields of papers citing papers by Xiaoshan Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoshan Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoshan Zhao. The network helps show where Xiaoshan Zhao may publish in the future.

Co-authorship network of co-authors of Xiaoshan Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoshan Zhao. A scholar is included among the top collaborators of Xiaoshan Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoshan Zhao. Xiaoshan Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and potential pharmacological mechanism of Astragalus-Salvia miltiorrhiza combination in diabetic nephropathy: integrating meta-analysis, network pharmacology, molecular docking, and experimental validation 2025 ·Renal Failure ·(unknown), (unknown), Mingmin Zhu, (unknown), (unknown), Jianfeng Chen, Jing Yuan, Pingping Jiang, Xiaoshan Zhao, Ya Xiao	1
2	Supercomputing Multi-Ligand Modeling, Simulation, Wavelet Analysis and Surface Plasmon Resonance to Develop Novel Combination Drugs: A Case Study of Arbidol and Baicalein Against Main Protease of SARS-CoV-2 2025 ·Pharmaceuticals ·Hong Li, (unknown), (unknown), (unknown), (unknown), Angela Wei Hong Yang, Xiaomin Sun, (unknown), (unknown), Andrew Hung, Xiaoshan Zhao	0
3	Molecular mechanisms of Lycii Fructus (Goji berries) against xanthine dehydrogenase in hyperuricemia management: Integrating computational, metabolomic, and experimental approaches 2025 ·Food Research International ·(unknown), (unknown), Yanting You, (unknown), Meiling Chen, Angela Wei Hong Yang, Xiaomin Sun, Andrew Hung, Xiaoshan Zhao, Hong Li	5
4	NOX4 as an emerging prognostic and immunological biomarker across pan-cancer analyses 2025 ·Scientific Reports ·Yusheng Liu, Chunying Wu, Qiang Wang, Xiaoshan Zhao, Xuefeng Jiang	1
5	Use of mobile fitness app to improve pelvic floor muscle training in puerperal women with gestational diabetes mellitus: A randomized controlled trial 2025 ·Health Informatics Journal ·(unknown), (unknown), Baoyuan Xie, (unknown), Honghui Zhang, Xiaoshan Zhao, Huifen Zhao	1
6	Silibinin attenuates ferroptosis in acute kidney injury by targeting FTH1 2024 ·Redox Biology ·(unknown), (unknown), Huaxi Liu, (unknown), Jie Zhou, Ying Yang, Yanting You, (unknown), (unknown), (unknown), Shuai Ji, Ming Wang, (unknown), Hiu Yee Kwan, (unknown), Qi Wang, Xiaoshan Zhao	32
7	Nanoplatform based on carbon nanoparticles loaded with doxorubicin enhances apoptosis by generating reactive oxygen species for effective cancer therapy 2024 ·Oncology Letters ·Yusheng Liu, Junfeng Zhang, Chunying Wu, (unknown), Huijie Fan, Qiang Wang, (unknown), (unknown), Xiaoshan Zhao, Xuefeng Jiang	1
8	Serum Uric Acid Levels Associated with Outcomes of Neurodegenerative Disorders and Brain Health: Findings from the UK Biobank 2024 ·The journal of nutrition health & aging ·(unknown), Jieyu Chen, (unknown), Shuai Ji, (unknown), (unknown), (unknown), (unknown), Jie Chen, (unknown), Hiu Yee Kwan, (unknown), Xiaoshan Zhao	2
9	Jiawei Yanghe Decoction suppresses breast cancer by regulating immune responses via JAK2/STAT3 signaling pathway 2023 ·Journal of Ethnopharmacology ·Yanting You, Xiaomei Chen, Xiaohu Chen, Hong Li, (unknown), (unknown), Meiling Chen, (unknown), Shuai Ji, Hiu Yee Kwan, (unknown), (unknown), Yanyan Liu, (unknown), Xiaoshan Zhao	26
10	β‐Sitosterol Suppresses LPS‐Induced Cytokine Production in Human Umbilical Vein Endothelial Cells via MAPKs and NF‐κB Signaling Pathway 2023 ·Evidence-based Complementary and Alternative Medicine ·(unknown), Hongfeng Liang, (unknown), (unknown), Wei Zhang, (unknown), Qiang Wang, Xuefeng Jiang, Xiaoshan Zhao, Huijie Fan	4
11	Uncovering the mechanism of Qidan Dihuang Granule in the treatment of diabetic kidney disease combined network pharmacology, UHPLC-MS/MS with experimental validation 2023 ·Heliyon ·Lei Xiang, Xiangsheng Cai, Xiaoshan Zhao, Yuanling Liu, Ya Xiao, Pingping Jiang, Lianghong Yin, Dan Song, Xuefeng Jiang	1
12	Multi-ligand molecular docking, simulation, free energy calculations and wavelet analysis of the synergistic effects between natural compounds baicalein and cubebin for the inhibition of the main protease of SARS-CoV-2 2023 ·Journal of Molecular Liquids ·Hong Li, (unknown), (unknown), (unknown), Angela Wei Hong Yang, Xiaomin Sun, Yanyan Liu, Andrew Hung, Xiaoshan Zhao, (unknown)	27
13	Research trends and prospects on brain metastasis from breast cancer: A bibliometric analysis 2023 ·Frontiers in Oncology ·Siqi Wu, Yan Liu, Jie Zhou, Yanting You, Xinghong Zhou, Liqian Chen, Hiu Yee Kwan, Xiaoshan Zhao, (unknown), Yanyan Liu	1
14	Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2 2023 ·Phytomedicine ·(unknown), Hao Duan, Yuheng Zou, Jing Wang, Huaxi Liu, Wanyu Wang, Zhu Xiao, Jiali Chen, Chuanwu Zhu, Zhixin Yin, Xiaoshan Zhao, Qirui Wang	13
15	Ginger Extract Decreases Susceptibility to Dextran Sulfate Sodium-Induced Colitis in Mice Following Early Antibiotic Exposure 2022 ·Frontiers in Medicine ·Xinghong Zhou, Xiaoyu Liu, (unknown), Ming Wang, (unknown), Yanting You, Liqian Chen, (unknown), Fei Li, Xiu‐Qiong Fu, Hiu Yee Kwan, Lin Zhou, Xiaoshan Zhao	10
16	Gancao Fuzi decoction regulates the Th17/Treg cell imbalance in rheumatoid arthritis by targeting Foxp3 via miR-34a 2022 ·Journal of Ethnopharmacology ·Xiaoshan Zhao, Yankui Yi, Cuiping Jiang, (unknown), (unknown), (unknown), (unknown), Yanyan Liu, Nan Li, Dongmei Pan	16
17	Guominkang formula alleviate inflammation in eosinophilic asthma by regulating immune balance of Th1/2 and Treg/Th17 cells 2022 ·Frontiers in Pharmacology ·Yumei Zhou, (unknown), Honglei Zhang, Haiyun Zhang, Juntong Liu, Xiaoshan Zhao, Ji Wang, Qi Wang	18
18	JMJD1A/NR4A1 Signaling Regulates the Procession of Renal Tubular Epithelial Interstitial Fibrosis Induced by AGEs in HK-2 2022 ·Frontiers in Medicine ·Shao‐Ting Wang, (unknown), (unknown), (unknown), (unknown), Wei Sun, Min Zhao, (unknown), (unknown), Xiaoshan Zhao, Donghui Liang, (unknown), Jia Sun, Ming Wang	11
19	Silibinin Induces G2/M Cell Cycle Arrest by Activating Drp1-Dependent Mitochondrial Fission in Cervical Cancer 2020 ·Frontiers in Pharmacology ·Yanting You, (unknown), (unknown), Xinghong Zhou, Liqian Chen, Huaxi Liu, Zibin Lu, (unknown), Yanyan Liu, Daming Zuo, Xiu‐Qiong Fu, Hiu Yee Kwan, Xiaoshan Zhao	28
20	Bu-Zhong-Yi-Qi pill alleviate the chemotherapy-related fatigue in 4 T1 murine breast cancer model 2014 ·BMC Complementary and Alternative Medicine ·Mingzi Ouyang, Yanyan Liu, Wei Tan, Ya Xiao, (unknown), Xiaomin Sun, Ying Huang, Jing-Ru C. Cheng, Ren Luo, Xiaoshan Zhao	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact